| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | November 20, 2024 |
| Accession Number: | 0001628280-24-048044 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | November 20, 2024 |
| Accession Number: | 0001628280-24-048044 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/9/2024 | Outperform → Peer Perform | Wolfe Research | |
| 7/19/2023 | $69.00 | Outperform | Robert W. Baird |
| 7/13/2023 | $70.00 | Overweight | KeyBanc Capital Markets |
| 5/23/2023 | $75.00 | Buy | CL King |
| 4/14/2023 | $75.00 | Buy | Mizuho |
| 3/24/2023 | $71.00 | Hold → Buy | Needham |
| 10/21/2022 | $85.00 | Outperform | RBC Capital Mkts |
| 10/12/2022 | $75.00 | Hold | Jefferies |